ANIK
ANIKA THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ANIKA THERAPEUTICS INC (ANIK) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$7.92M; the largest are Renaissance Technologies, Paul Tudor Jones, Steven Cohen. This quarter: 2 new, 2 trimmed, 1 closed. 8 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders4
Congress trades8
Price$19.94vs quarter-end+36.33%
Sectors0
This quarter's moves
Top holderNew2
Added0
Trimmed / sold3
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.